In May 2016, researchers at the now-defunct StemCells Inc., Newark, California, terminated a Phase 2 trial of neural stem cells for spinal cord injury due to lack of efficacy. Now, two papers in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback